|
Days
|
VA OD
|
VA OS
|
IOP OD (mmHg)
|
IOP OS (mmHg)
|
CCT OD (µm)
|
CCT OS (µm)
|
|---|
|
Baseline
|
20/26
|
20/46
|
12
|
17
|
562
|
557
|
|
Rhopressa started
|
20/20
|
20/200
|
12
|
7
|
549
|
808
|
|
Rhopressa discontinued week 2
|
20/20
|
20/40
|
15
|
17
|
549
|
589
|
|
Week 3
|
20/20
|
20/30
|
12
|
13
|
560
|
590
|
|
Month 2
|
20/20
|
20/70
|
7
|
10
|
571
|
618
|
|
Month 3
|
20/20-2
|
20/70
|
11
|
11.5
|
579
|
633
|
|
Month 4
|
20/20
|
20/30
|
11
|
14
|
542
|
560
|
- The patient presented with a significant increase in CCT OS. VA visual acuity, OD right eye, OS left eye, CCT central corneal thickness, IOP intraocular pressure
